A67+A69

The company is engaged in the production and marketing of health products, primarily dietary supplements and medical devices. Born as a trading company, later transformed into a manufacturing company, it underwent a real turning point in 2009, with the inauguration of the new 5200 square meter production plant, built to ensure pharmaceutical-grade quality standards to customers. Evolving from a standalone entity, Erbozeta S.p.A. expanded into a group by establishing new trading companies: Pharmaluce S.r.l. in 2008, Logus Pharma S.r.l. in 2013, Erbozeta Austria in 2013, Erbozeta Asia in 2015, and Erbozeta Iberica in 2019. Erbozeta has managed to expand its business to more than 70 countries worldwide and is now a reference point in the market for dietary supplements and medical devices at both national and international levels.